Physician-Led Individualized Weight Loss
Your Body. Your Results.
Weekly provider check-ins. Adjustments based on your progress. Care that evolves with you.
Our Clinical Results
Results from two peer-reviewed, retrospective studies of Ivím patients who stayed on treatment. Most used compounded medications. Not head-to-head comparisons. Individual results vary. See study details below.
¹ 26.5% average total body weight loss at 72 weeks among Ivím tirzepatide patients who stayed on treatment. ² 21.8% average at 68 weeks among Ivím semaglutide patients who stayed on treatment. ³ 21.8% average weight loss at 68 weeks for Ivím semaglutide patients who stayed on treatment under the Ivím Protocol vs. 16.9% for participants who adhered to treatment in a separate published semaglutide trial that included structured diet, exercise, and counseling. Retrospective study with no control group. Differences may reflect care model, population, and study design, and the study does not establish that the Ivím Protocol caused the difference. Not a head-to-head comparison, and not evidence that any medication is more effective than another. More than 90% of Ivím patients used compounded medications. Results are from two retrospective studies with no control group, published in Obesity Pillars. More than 90% of Ivím patients used compounded medications.
Patients trust us. The rankings agree.
How It Works
Complete Your Health Questionnaire
Complete a health questionnaire so your provider can assess your eligibility.
Meet With Your Provider
A video or chat visit with an Ivím provider to review your history and goals and build your treatment plan.
Start & Adjust Your Plan
Select your individualized plan. Your provider finalizes your care and sends your prescription to the pharmacy.
What to Expect
Your Ivím GLP-1 Patient Journey
Check In
A quick weekly check-in in the app: how you’re feeling, any side effects, and where your weight and progress stand.
Custom Adjustments
Your provider reviews each check-in and fine-tunes your dose or protocol to match how your body is responding.
Feel the Difference
Your plan is tuned to you week over week, with the goal of fewer side effects and steadier progress.
The Ivím GLP-1 Program May Be Right for You if…
- You want weight-loss care tailored to your individualized progress.
- You want regular provider check-ins and adjustments as your needs change.
- You want ongoing support beyond receiving a prescription.
- You want a treatment plan that considers your individual goals and experience.
What Your Program Includes
| Ivím | Other Competitors | Traditional Medicine | |
|---|---|---|---|
| Individualized GLP-1 care model | Included | Not included | In-clinic only |
| Unlimited provider access | Included | Not included | Not included |
| Weekly dose adjustments | Included | Not included | Not included |
| 1:1 Virtual Holistic Consultations ($850 value) | Included | Not included | Not included |
| Master classes, group coaching & community ($500 value) | Included | Limited | Not included |
| 20% off physician-formulated supplements | Included | Not included | Not included |
| Easy progress tracking with the Ivím Health App | Included | Not included | Limited |
Your Care Plan
Ivím offers both FDA-approved medications and compounded medications. Compounded drugs are permitted under federal law but are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Prescription required after provider evaluation.
Common Questions
What are the most common side effects of compounded GLP-1 medications?
The most common side effects of compounded semaglutide and compounded tirzepatide are typically gastrointestinal in nature, including:
Nausea Vomiting Diarrhea Constipation Bloating or gas Decreased appetite or early satiety
These side effects are usually mild to moderate and tend to improve over time, especially with gradual dose escalation under provider supervision. Serious side effects can also include pancreatitis, gallbladder problems, low blood sugar, kidney problems, thyroid C-cell tumor warning.
Are GLP-1s covered by insurance?
Branded GLP-1 medications may be covered by insurance, depending on your specific plan and carrier requirements. Eligibility is often based on factors such as BMI, medical history, and qualifying health conditions. Before you get started, Ivím can help verify your insurance coverage to determine whether you qualify.
What if I prefer branded medications?
Zepbound® and Wegovy® are available through our traditional GLP-1 program when your provider determines they’re appropriate.
How do I know if I’m eligible?
Our intake questionnaire and consultation with a provider determine if you medically qualify.
How does canceling work?
Your GLP-1 membership auto-renews until you cancel, and you can cancel online from your account (https://www.ivimhealth.com/my-account/). Canceling doesn’t refund any fees already paid or pause your program period, though: your program keeps running toward its fixed end date, and any medication not yet shipped is forfeited once your program period and 14-day grace period expire. You’ll still owe for any medication already dispensed or prepared and any membership fees accrued before cancellation. Refunds are only available as described in our Refund and Returns Policy (https://www.ivimhealth.com/refund_returns/).
Support At Every Step
“For years, the advice was simple: eat less, move more. It’s not that simple. Hunger, metabolism, your body’s set point, those are biological signals, and it’s not always something you can control. When you treat weight the way you’d treat any other medical condition, real change becomes possible.”
Jessica Duncan, MD Chief Medical Officer
Ivím offers FDA-approved and compounded medications. Compounded drugs are permitted under federal law but are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Prescription required after provider evaluation. Individual results vary. Not available in all states. See full safety information. Zepbound® and Wegovy® are registered trademarks of their respective owners.